Medical management of carotid stenosis
1Cardiovascular Division, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA. shields.raymond@mayo.edu
Insights
Stroke risk management needs improvement, especially hypertension and carotid artery disease. Optimal medical care now includes aggressive risk reduction, particularly antihyperlipidemic therapy, for better stroke prevention.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Public Health
Background:
- Stroke remains a major cause of death and disability globally.
- While stroke rates decline in North America, opportunities for improved risk stratification and management persist.
- Hypertension is a primary modifiable risk factor for stroke.
Purpose of the Study:
- To review current strategies for stroke risk stratification and management.
- To highlight the role of carotid atherosclerotic disease in ischemic strokes.
- To discuss the evolving landscape of carotid stenosis treatment, including medical management and carotid endarterectomy (CEA).
Main Methods:
- Literature review of stroke epidemiology and risk factors.
- Analysis of current guidelines and evidence for carotid stenosis management.
- Evaluation of the impact of medical management advancements, including antihyperlipidemic therapy.
Main Results:
- Hypertension is the most significant modifiable stroke risk factor.
- Carotid atherosclerotic disease accounts for 15% of ischemic strokes.
- Medical management, especially with antihyperlipidemic therapy, has improved significantly, impacting treatment decisions for carotid stenosis.
Conclusions:
- Despite decreased stroke rates, improved risk stratification and management are crucial.
- Optimal medical management for stroke prevention requires aggressive risk factor reduction.
- Further understanding of carotid atherosclerosis natural history is needed to refine management strategies.
Abstract:
Stroke is a leading cause of morbidity and mortality in the developed world. Although the rates of stroke have decreased in North America, there are significant areas of risk stratification and management that can be improved. Hypertension is the most significant and perhaps most modifiable risk factor for stroke. Carotid atherosclerotic disease is associated with 15% of ischemic strokes. Although carotid endarterectomy (CEA) remains a recommendation for significant symptomatic carotid stenosis, controversy continues in the management of asymptomatic and recurrent carotid stenosis. Medical management options and effectiveness has significantly improved since the early CEA trials were published. Optimal medical management now must incorporate aggressive risk factor reduction measures, particularly with antihyperlipidemic therapy. Improved understanding of the natural history of carotid atherosclerosis is necessary to improve the application of management strategies.
Related Concept Videos
Atherosclerosis III: Management
Angina IV: Management
Mitral Stenosis III: Medical Management
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis IV: Nursing Management

